Unichem Laboratories Ltd. — Regulatory Filings 2021

Jun 11, 2021

==> picture [190 x 43] intentionally omitted <==

June 11, 2021

The Secretary The Manager Listing Department Listing Department Bombay Stock Exchange Ltd. National Stock Exchange of India Ltd Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra – Kurla Complex Dalal Street, Bandra (East), Mumbai – 400 051 Mumbai- 400 001 Scrip Code -506690 Stock Symbol – UNICHEMLAB

Sub: Disclosure of Related Party Transactions pursuant to Regulation 23(9) of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") for half year ended March 31, 2021

Dear Sir/Madam,

Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed the disclosure of Related Party Transactions on a consolidated basis for half year ended March 31, 2021 drawn in accordance with the applicable Accounting Standards.

Kindly take the same on your records.

Thanking you,

Yours truly,

For UNICHEM LABORATORIES LIMITED

PRADEEP Digitally signed by PRADEEP BHANDARI BHANDARI Date: 2021.06.11 16:55:34 +05'30' PRADEEP BHANDARI Head Legal & Company Secretary

Encl : As above

==> picture [189 x 32] intentionally omitted <==

Registered Office: Unichem Bhavan, Prabhat Estate, Off S. V. Road Jogeshwari (West), Mumbai – 400 102, Maharashtra, India.

UNICHEM LABORATORIES LIMITED

Disclosure of related party transactions for the half year ended 31st March, 2021 (on consolidated basis)

RELATED PARTY DISCLOSURES

Disclosure of related parties / related party transactions pursuant to Ind AS 24 "Related Party Disclosure".

a) List of related parties

(i) Enterprises under significant influence of Uni - Distributors Pvt. Ltd. Uni Trust Also Refer note (f) key management personnel as defined in (ii) (disclosed to the extent of transactions)	(ii) Key management personnel and their relatives: Dr. Prakash A. Mody (Chairman & Managing Director - CMD,Promoter) Mrs Anita Mody (Spouse of CMD) Ms Supriya Mody (Daughter of CMD) Ms. Suparna Mody (Daughter of CMD) Mr. Dilip J. Kunkolienkar (Director - Technical)
(iii) Independent Directors: Dr. (Mrs.) B. Kinnera Murthy Mr. Anand Y. Mahajan Mr. Prafull Anubhai Mr. Prafull D Sheth	(iv) Post-employment benefit plans: Unichem Laboratories Ltd- Employees Gratuity Fund Unichem Laboratories Ltd- Employees Superannuation Fund
(v) Key management personnel and their: relatives as per Companies Act, 2013. Mr. Pradeep Bhandari- (Head-Legal & Company Secretary) Mr. Sandip Ghume (Dy. Chief Financial Officer)

• b) Disclosure of related party transactions :

c)		(Rs. in lakhs)
	Particulars	Half Year Ended 31st March, 2021
	i) Rent & Maintenance Paid (excluding indirect taxes) Relative of Key Management Personnel Mrs Anita Mody Enterprise under significant influence of Key Management Personnel Uni - Distributors Pvt. Ltd. Uni Trust ii) Managerial remuneration ( including defined contribution plan) Key Management Personnel Dr. Prakash A. Mody Mr. Dilip J Kunkolienkar iii) Salary ( including defined contribution plan) Relative of Key Management Personnel Ms Supriya Mody iv) Sitting Fees Independent Directors Dr. (Mrs.) B. Kinnera Murthy Mr. Anand Y. Mahajan Mr. Prafull Anubhai Mr. Prafull D Sheth	9.33 5.85 4.50
		19.68
		296.99 98.61
		395.60
		43.37
		43.37
		5.00 5.00 5.50 5.00
		20.50
	Disclosure of related party balances :	(Rs. in Lakhs)
	Particulars	YTD 31st March, 2021
	i) Deposits paid Relative of Key Management Personnel Mrs Anita Mody Enterprise under significant influence of Key Management Personnel Uni - Distributors Pvt. Ltd. Uni Trust ii) Other Current Liabilities Dr. Prakash A. Mody Key Management Personnel	45.90 5.00 2.25
		53.15
		50.85
		50.85

==> picture [49 x 47] intentionally omitted <==

==> picture [93 x 28] intentionally omitted <==

UNICHEM LABORATORIES LIMITED Disclosure of relatedparty transactions for the halfyear ended 31st March, 2021(on consolidated basis)	UNICHEM LABORATORIES LIMITED Disclosure of relatedparty transactions for the halfyear ended 31st March, 2021(on consolidated basis)	UNICHEM LABORATORIES LIMITED Disclosure of relatedparty transactions for the halfyear ended 31st March, 2021(on consolidated basis)	UNICHEM LABORATORIES LIMITED Disclosure of relatedparty transactions for the halfyear ended 31st March, 2021(on consolidated basis)
d) e) 1 2 3 f)	Contribution to post employment benefit plan :		(Rs. in Lakhs)
	Particulars		Half Year Ended 31st March, 2021
	Post-employment benefit plans Unichem Laboratories Ltd - Employees Gratuity Fund Unichem Laboratories Ltd - Employees Superannuation Fund		9.97 43.00
			52.97
	Following are Key management Personnel (not covered above) in accorda balances are below :		(Rs. in Lakhs) nce with provisions of Companies Act, 2013. Details of transactions and
	Particulars		Half Year Ended 31st March, 2021
	Salary ( including defined contribution plan) Key Management Personnel Mr. Pradeep Bhandari Mr. Sandip Ghume		38.66 26.09
			64.75
	Particulars Half Year Ended 31st March, 2021 7.59 Rent Income ( excluding indirect tax) 23.06 Deposit received(closingbalance as on 31st March,2021) 7.50 Key Managerial Personnel and their Relatives who are under the employment of the Company are entitled to post employment benefits and other long term employee benefits recognised as per Ind AS 19 - ‘Employee Benefits’ in the financial statements. As these employee benefits are lump sum amounts provided on the basis of actuarial valuation, the same is not included above. Further, it also does not include actual payments of gratuity and leave encashment. Also, re- imbursement of expenses to KMP and their relatives are not included above. Number of option pending to be exercised by Mr. Dilip Kunkolienkar as on 31st March, 2021 are 2,46,176 (P.Y. 2,46,176). Research & Development Expenditure (Bio-equivalence studies) (excluding indirect tax) Related party contracts / arrangements have been entered in ordinary course of business and are approved by the board of directors/ shareholders as applicable. In view of the Management , equity Investment in Synchron Research Services Pvt Ltd will not result the investee company becoming a related party since there is no control / influence over operations : The summary of transactions and closing balances with Synchron Research Services Pvt. Ltd are as follows:
		Particulars	Half Year Ended 31st March, 2021
		Rent Income ( excluding indirect tax) Deposit received(closingbalance as on 31st March,2021) Research & Development Expenditure (Bio-equivalence studies) (excluding indirect tax)	7.59 23.06 7.50

==> picture [49 x 47] intentionally omitted <==

==> picture [93 x 28] intentionally omitted <==